XAIR Relative Valuation
XAIR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XAIR is overvalued; if below, it's undervalued.
Historical Valuation
Beyond Air Inc (XAIR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.98 is considered Undervalued compared with the five-year average of -2.52. The fair price of Beyond Air Inc (XAIR) is between 4.24 to 12.13 according to relative valuation methord. Compared to the current price of 3.20 USD , Beyond Air Inc is Undervalued By 24.59%.
Relative Value
Fair Zone
4.24-12.13
Current Price:3.20
24.59%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.97
P/B
Median3y
2.53
Median5y
3.49
-286.30
FCF Yield
Median3y
-117.99
Median5y
-76.20
Competitors Valuation Multiple
The average P/S ratio for XAIR's competitors is 3.49, providing a benchmark for relative valuation. Beyond Air Inc Corp (XAIR) exhibits a P/S ratio of 0.97, which is -72.30% above the industry average. Given its robust revenue growth of 145.11%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

XAIR.O
Beyond Air Inc
0.97
Average P/S: 3.49
145.11%
14.85M

ICU.O
SeaStar Medical Holding Corp
12.33
13.37M

MHUA.O
Meihua International Medical Technologies Co Ltd
Loss
12.13M

TRIB.O
Trinity Biotech PLC
0.27
3.24%
12.49M

CTXR.O
Citius Pharmaceuticals Inc
0.48
18.66M

BRTX.O
BioRestorative Therapies Inc
6.88
-28.57%
12.16M
People Also Watch

VCIG
VCI Global Ltd
1.230
USD
+36.20%

GRYP
Gryphon Digital Mining Inc
1.210
USD
+0.83%

CVM
CEL-SCI Corp
8.200
USD
+19.71%

AKTX
Akari Therapeutics PLC
1.120
USD
+1.82%

AACG
ATA Creativity Global
1.007
USD
-6.76%

AAME
Atlantic American Corp
2.270
USD
0.00%

MRNS
Marinus Pharmaceuticals Inc
0
USD
0.00%

FLUX
Flux Power Holdings Inc
1.830
USD
-6.63%

LIVE
Live Ventures Inc
16.230
USD
+1.06%

STBX
Starbox Group Holdings Ltd
0
USD
-9.95%
FAQ

Is Beyond Air Inc (XAIR) currently overvalued or undervalued?
Beyond Air Inc (XAIR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.98 is considered Undervalued compared with the five-year average of -2.52. The fair price of Beyond Air Inc (XAIR) is between 4.24 to 12.13 according to relative valuation methord. Compared to the current price of 3.20 USD , Beyond Air Inc is Undervalued By 24.59% .

What is Beyond Air Inc (XAIR) fair value?

How does XAIR's valuation metrics compare to the industry average?

What is the current P/B ratio for Beyond Air Inc (XAIR) as of Jul 27 2025?

What is the current FCF Yield for Beyond Air Inc (XAIR) as of Jul 27 2025?

What is the current Forward P/E ratio for Beyond Air Inc (XAIR) as of Jul 27 2025?
